Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)

v3.10.0.1
Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)
6 Months Ended
Jun. 30, 2018
USD ($)
$ / shares
shares
Equity [Abstract]  
Stock Option Outstanding, Beginning Balance | shares 93,203,369
Stock Option Outstanding, Granted | shares
Stock Option Outstanding, Cancelled | shares
Stock Option Outstanding, Exercised | shares
Stock Option Outstanding, Ending Balance | shares 93,203,369
Stock Option Outstanding, Exercisable | shares 93,203,369
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 0.029
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price, Cancelled | $ / shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Ending Balance | $ / shares 0.029
Weighted Average Exercise Price, Exercisable | $ / shares $ 0.029
Weighted Average Remaining Contractual Term (years), Outstanding Beginning 3 years 11 months 15 days
Weighted Average Remaining Contractual Term (years), Outstanding Ending 3 years 5 months 16 days
Weighted Average Remaining Contractual Term (years), Exercisable 3 years 5 months 16 days
Aggregated Intrinsic Value, Outstanding | $ $ 624,463
Aggregated Intrinsic Value, Exercisable | $ $ 624,463